Listed

Fitlife Brands, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 14, 2016 and accepted by EDGAR at Nov 14, 2016, 18:37 ET.

Share

Management's discussion and analysis

As filed, 14,905 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

Management’s Discussion and Analysis contains various “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to “anticipates”, “believes”, “plans”, “expects”, “future” and similar statements or expressions, identify forward looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company’s business, including but not limited to, reliance on key customers and competition in its markets, market demand, product performance, technological developments, maintenance of relationships with key suppliers, difficulties of hiring or retaining key personnel and any changes in current accounting rules, all of which may be beyond the control of the Company. The Company adopted at management’s discretion, the most conservative recognition of revenue based on the most astringent guidelines of the SEC. Management will elect additional changes to revenue recognition to comply with the most conservative SEC recognition on a forward going accrual basis as the model is replicated with other similar markets. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth therein.

Forward-looking statements involve risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those identified in the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as well as other factors that we are currently unable to identify or quantify, but that may exist in the future.

In addition, the foregoing factors may affect generally our business, results of operations and financial position. Forward-looking statements speak only as of the date the statement was made. We do not undertake and specifically decline any obligation to update any forward-looking statements.

Overview

FitLife Brands, Inc. (the “Company”) is a national provider of innovative and proprietary nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition ProductsTM (“*NDS”) (*www.ndsnutrition.com (http://www.ndsnutrition.com)), PMDTM (www.pmdsports.com (http://www.pmdsports.com)), SirenLabsTM (www.sirenlabs.com (http://www.sirenlabs.com)), CoreActiveTM (www.coreactivenutrition.com (http://www.coreactivenutrition.com)), and Metis NutritionTM (www.metisnutrition.com (http://www.metisnutrition.com)) (together, “NDS Products”). With the consummation of the merger with iSatori, Inc. (“iSatori”) on September 30, 2015, which became effective on October 1, 2015, described below (the “Merger”), the Company added several brands to its product portfolio, including iSatori (www.isatori.com (http://www.isatori.com)), CT Fletcher, BioGenetic Laboratories, and Energize (together, “iSatori Products”). The NDS Products are distributed principally through franchised General Nutrition Centers, Inc. (“GNC”) stores located both domestically and internationally, and, with the addition of Metis Nutrition, through corporate GNC stores in the United States. The iSatori Products are sold through more than 25,000 retail locations, which include specialty, mass, and online.

The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS Nutrition Products, Inc., a Florida corporation (“NDS”). The Company’s NDS Products are sold through NDS and the iSatori Products are sold through iSatori, Inc., a Delaware corporation and a wholly owned subsidiary of the Company.

FitLife Brands is headquartered in Omaha, Nebraska and maintains an office in Golden, Colorado, which it acquired in connection with the Merger. For more information on the Company, please go to http://www.fitlifebrands.com. The Company’s common stock currently trades under the symbol FTLF on the OTC:PINK market.

Results of Operations

Comparison of Three and Nine Months Ended September 30, 2016 to the Three and Nine Months Ended September 30, 2015

Net Sales. Revenue for the three months ended September 30, 2016 decreased 14.8% to $5,340,616 as compared to $6,270,524 for the three months ended September 30, 2015. Revenue for the three months ended September 30, 2016 for the Company’s NDS Nutrition division decreased 32.9% to $4,206,557 as compared to $6,270,524 for the three months ended September 30, 2015, as originally reported. Revenue for the three months ended September 30, 2015 included $567,462 in vendor funded discounts originally reported as a selling and marketing expense, but subsequently reclassed to a reduction in revenue for the full year financial results for 2015 as reported on the Company’s Form 10-K for the year ended December 31, 2015. As adjusted for the accounting treatment change, revenue the NDS Nutrition division for the three months ended September 30, 2016 decreased $1,496,505 to $4,206,557 as compared to $5,703,062 for the three months ended September 30, 2015.

Revenue attributable to the Company’s iSatori operating division, which had no impact on the three months ended September 30, 2015, was $1,134,058. The decrease in total revenue in the three months ended September 30, 2016 compared to the comparable period last year is principally attributable to both lower revenue at the Company’s iSatori division as well as the timing of GNC’s 2016 annual franchise convention, which resulted in increased sales in the quarter ended June 30, 2016 that would have historically been recognized in the third quarter. Management estimates that it shipped approximately $1.3 million the second quarter related to the annual convention that otherwise would have historically been recognized during the third quarter.

Revenue for the nine months ended September 30, 2016 increased 42.8% to $21,615,605 as compared to $15,139,949 for the nine months ended September 30, 2015. Revenue for the nine months ended September 30, 2016 for the Company’s NDS Nutrition division increased 2.1% to $15,463,141 as compared to $15,139,949 for the nine month period ended September 30, 2015. Revenue for the Company’s NDS Nutrition division for the nine month period ended September 30, 2015, included $1,063,312 in vendor funded discounts originally recorded as a selling and marketing expense but reclassed as an offset to revenue for the full year financial results as reported on the Company’s Form 10-K for the year ended December 31, 2015. As adjusted for the accounting treatment change, revenue for the NDS Nutrition division for the nine months ended September 30, 2016 increased 9.8% to $15,463,141 as compared to $14,076,637 for the nine month period ended September 30, 2015. Revenue for the Company’s iSatori division for the nine month period ended September 30, 2016 was $6,152,464. The increase in total revenue for the nine month period ended September 30, 2016 was driven by continued improvement in sales of product through GNC, and the addition of revenue attributable to iSatori Products.

The Company continually reformulates and introduces new products, as well as seeks to increase both the number of stores and number of approved products that can be sold within the GNC franchise system that comprise its domestic and international distribution footprint and, while no assurances can be given, anticipates that such efforts together with anticipated sales growth attributable to iSatori Products will continue to drive future revenue growth. In addition, management believes that GNC’s initiative to sell corporate owned stores to franchisees will also drive revenue growth. While currently not a material component of revenue, management anticipates that continued international expansion within the GNC franchise system, as well as the introduction of new NDS Products and iSatori Products will also contribute to future growth.

Cost of Goods Sold. Cost of goods sold for the three months ended September 30, 2016 decreased to $3,353,224 as compared to $3,658,541 for the three months ended September 30, 2015, and increased to $12,469,081 during the nine months ended September 30, 2016 as compared to $9,015,846 for the nine months ended September 30, 2015. The decrease during the three-month period is principally attributable to lower sales in the period, and the increase in cost of goods sold for the nine-month period was primarily attributable to increased sales volumes including sales of iSatori Products during such nine-month period.

General and Administrative Expense. General and administrative expense for the three months ended September 30, 2016 increased to $1,131,692 as compared to $854,729 for the three months ended September 30, 2015. General and administrative expense for the nine months ended September 30, 2016 increased to $3,854,128 as compared to $2,469,866 for the nine months ended September 30, 2015. The increase in general and administrative expense for the three and nine months ended September 30, 2016 and 2015 is principally attributable to the continued integration of iSatori operations following completion of the Merger.

Selling and Marketing Expense. Selling and marketing expense for the three months ended September 30, 2016 decreased to $1,088,400 as compared to $1,258,537 for the three months ended September 30, 2015, and increased to $3,138,323 during the nine months ended September 30, 2016 as compared to $2,773,293 for the nine months ended September 30, 2015. Selling and marketing expense for the three and nine month periods ended September 30, 2015 included $567,462 and $1,063,312 in vendor funded discounts not recorded as an offset to revenue. The change in selling and marketing expense for the three- and nine-month period ended September 30, 2016 is principally attributable to the addition of iSatori, which was offset by the accounting policy change for vendor funded discounts. As net sales increase, selling and marketing expense is anticipated to simultaneously increase, although management anticipates that selling and marketing expense will increase at a slower rate.

Depreciation and Amortization. Depreciation and amortization for the three months ended September 30, 2016 increased to $125,751 as compared to $55,472 for the three months ended September 30, 2015. Depreciation and amortization for the nine months ended September 30, 2016 increased to $376,502 as compared to $166,137 for the nine months ended September 30, 2015. The increase is principally attributable to the addition of iSatori.

Net Income/(Loss). We generated a net loss of $360,718 for the three-month period ended September 30, 2016, and net income of $1,532,472 for the nine months ended September 30, 2016, as compared to a profit of $383,258 for the three months ended September 30, 2015 and a profit of $584,533 for the nine months ended September 30, 2015. The decrease in net income for the three-month period ended September 30, 2016 compared to the comparable period last year is principally attributable to lower revenue in the current period compared to the quarter ended September 30, 2015, while the increase in net income in the nine month period ended September 30, 2016 compared to the comparable period last year is principally attributable to increased sales volume of NDS Products, sales of iSatori Products and continued strong gross margins.

Liquidity and Capital Resources

The Company has historically financed its operations primarily through equity and debt financings, and more recently, cash flow from operations. The Company has also provided for its cash needs by issuing common stock, options and warrants for certain operating costs, including consulting and professional fees. The Company did not engage in any financing activities during the quarter ended September 30, 2016. The anticipated cash derived from operations and existing cash resources are expected to provide for the Company’s liquidity for the next 12 months.

Cash Provided by/(Used in) Operations. Our cash provided by operating activities for the nine months ended September 30, 2016 was $357,665, as compared to cash used in operating activities of ($518,159) for the nine months ended September 30, 2015. The increase is attributable to increased revenue, including increased accounts receivables and inventories balances due, in part, to the addition of iSatori operations and sales, as well as variations in certain working capital accounts consistent with normal business practices and outcomes. Net working capital decreased to $4,758,923 as of the quarter ended September 30, 2016 compared to $7,414,162 as of September 30, 2015.

Cash Provided by/(Used in) Investing Activities. Cash used in investing activities for the nine months ended September 30, 2016 was $(19,592) as compared to $(402,315) used in investing activities for the nine months ended September 30, 2015. The primary difference was related to a temporary reduction in activity related to the Company’s stock buyback program.

Cash Provided by/(Used in) Financing Activities. Our cash provided by financing activities for the nine months ended September 30, 2016 was $115,739, as compared to $(378,561) cash used in financing activities during the nine months ended September 30, 2015. We drew down $520,000 during the nine months ended September 30, 2016 from our existing line of credit with U.S. Bank. We expect to pay back all amounts borrowed under this line of credit, as well as any outstanding principal under the Company’s existing term loan with U.S. Bank as soon as practicable.

WHERE YOU CAN FIND MORE INFORMATION

You are advised to read this Quarterly Report on Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

Market risk

As filed, 1,411 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business is currently conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although as the geographical scope of our business broadens, we may do so in the future.

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash equivalents consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.

We do not hold any derivative instruments and do not engage in any hedging activities.

Controls and procedures

As filed, 3,992 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives. As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control — Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management has used the framework set forth in the report entitled Internal Control-Integrated Framework published by the COSO to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, our Chief Executive Officer and Chief Financial Officer have concluded that our internal control over financial reporting was effective as of September 30, 2016. This Quarterly Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our internal control over financial reporting was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

(b) Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal controls over financial reporting or in other factors that could materially affect, or are reasonably likely to affect, our internal controls over financial reporting during the quarter ended September 30, 2016. There have not been any significant changes in the Company's critical accounting policies identified since the Company filed its Annual Report on Form 10-K as of December 31, 2015.

PART II

OTHER INFORMATION

Risk factors

As filed, 213 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$5.3mus-gaap:Revenues
Revenue9 months2016-01-01 to 2016-09-30$21.6mus-gaap:Revenues
Cost of revenue3 months2016-07-01 to 2016-09-30$3.4mus-gaap:CostOfGoodsSold
Cost of revenue9 months2016-01-01 to 2016-09-30$12.5mus-gaap:CostOfGoodsSold
Gross profit3 months2016-07-01 to 2016-09-30$2.0mus-gaap:GrossProfit
Gross profit9 months2016-01-01 to 2016-09-30$9.1mus-gaap:GrossProfit
Operating income3 months2016-07-01 to 2016-09-30−$358.5kus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30$1.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-07-01 to 2016-09-30$27.4kus-gaap:InterestExpense
Interest expense9 months2016-01-01 to 2016-09-30$84.0kus-gaap:InterestExpense
Income tax3 months2016-07-01 to 2016-09-30−$25.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-01-01 to 2016-09-30$164.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-07-01 to 2016-09-30−$360.7kus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30$1.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30$0.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-07-01 to 2016-09-30−$0.03us-gaap:EarningsPerShareBasic
Basic EPS9 months2016-01-01 to 2016-09-30$0.05us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-07-01 to 2016-09-3010,446,954 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-01-01 to 2016-09-3011,515,169 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2016-01-01 to 2016-09-30$357.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2016-01-01 to 2016-09-30$21.6kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2016-01-01 to 2016-09-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-09-30$2.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$10.7mus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$18.2mus-gaap:Assets
Current liabilitiesAt period end2016-09-30$5.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$6.4mus-gaap:Liabilities
Long-term debtAt period end2016-09-30$507.3kus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2016-09-30$540.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2016-09-30$11.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001415889-16-007414. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.